<DOC>
	<DOCNO>NCT01478516</DOCNO>
	<brief_summary>The purpose study evaluate prospective study efficacy intravitreal autologous plasmin enzyme macular edema analyze fibrinolytic system vitreous body .</brief_summary>
	<brief_title>Autologous Plasmin Fibrinolytic System Diabetic Retinopathy</brief_title>
	<detailed_description>Autologous plasmin enzyme use liquefy gel structure vitreous body decrease adherence posterior vitreous cortex inner limit membrane clinical study . The investigator perform intravitreal autologous plasmin enzyme macular edema . addition , investigator collect vitreous body macular edema analyze fibrinolytic system .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Fibrinolysin</mesh_term>
	<criteria>eye macular edema show poor outcome visual acuity macular thickness grid laser , triamcinolone , bevacizumab therapy combination treatment . uncontrolled blood pressure ( systolic diastolic blood pressure great 150 90 mm Hg , respectively ) renal insufficiency intraocular surgery intravitreal treatment previous 3 month history ocular hypertension and/or glaucoma</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>autologous plasmin</keyword>
	<keyword>macular edema</keyword>
	<keyword>vitreous</keyword>
</DOC>